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In recent years, phosphodiesterase (PDE) inhibitors, such as amrinone, milrinone and olprinone, have been widely used in patients with severe heart failure, and their combination of positive inotropic and vasodilator activities have been reported. [2] [3] [4] [5] Milrinone is new and its pharmacological effect is 10-30 times the potency of the parent compound, amrinone, which is most commonly uesd at present. 2 Another newly developed PDE inhibitor, olprinone, has been evaluated also and demonstrated to have a positive inotropic effect with little increase in heart rate and a remarkable vasodilating effect. 6, 7 However, as for their efficacy for weaning from cardiopulmonary bypass (CPB) and after cardiac surgery, few data are available so far. In addition, an appropriate infusion method of milrinone or olprinone has not been established. To estimate the effectiveness of milrinone and olprinone for weaning from CPB and after cardiac operations, a clinical study was done in elective coronary artery bypass grafting (CABG) cases.
Methods
Between September 1995 to September 1997, 34 consecutive patients underwent elective CABG at the Nihon University School of Medicine. Exclusion criteria for this study included emergency operation, elderly (>75 year old), pre-operative low left ventricular ejection fraction less than 40%, and hypotension (<100 mmHg of systolic aortic pressure). In all cases, normothermia and cardioplegic (St. Thomas solution) cardiac arrest were performed under conventional CPB, using a centrifugal pump (Nikkiso HP-15, Nikkiso Co Ltd, Tokyo and BioMeducus BP-80, Medtronic Inc, MN). Intra-aortic balloon catheters were only used before the operation to prevent infarction.
According to the drugs that were used for weaning from CPB, the cases were divided into 3 groups. In 12 cases, continuous intravenous infusion of milrinone (0.25 g kg -1 min -1 ), concomitantly with the inotropic agents dobutamine (DOB) and dopamine (DOA) at 3 g kg -1 min -1 as the initial dose (Group-M). In another 10 patients 0.1 g kg -1 min -1 of olprinone and the same initial doses of catecholamines (DOB and DOA) were administered concomitantly (Group-O). As a control, the same initial doses of catecholamines were given to 12 patients (Group-C). The drugs were administered to all groups in the weaning period when the pump flow decreased to half of the full flow of CPB. No other inotropic agents, nitroglycerin, vasodilators or calcium antagonist were used in the 3 groups.
Hemodynamic data were recorded before CPB, just after . Using this system, systolic, mean and diastolic pulmonary artery pressure (PAP), pulmonary capillary wedge pressure (PCWP), cardiac index (CI) and mixed venous oxygen saturation (SvO2) were measured, and the systemic vascular resistance index (SVRI) and pulmonary vascular resistance index (PVRI) were calculated. In addition, oxygen delivery (DO2) and oxygen consumption (VO2) were also calculated as the parameters of oxygen supply and demand in peripheral tissue. 8 Using these 2 calculations, the oxygen extraction ratio (ER) was evaluated and compared between the 3 groups. These 3 parameters were calculated by the following equations. DO2 = Cardiac output × artery O2 content (CaO2) VO2 = Cardiac output × (artery O2 content (CaO2) -mixed venous O2 content (CvO2)) ER = (artery O2 content (CaO2) -mixed venous O2 content (CvO2)) / artery O2 content (CaO2) = VO2 / DO2 Data are expressed as the mean ± standard deviation (SD). Statistical analysis of variance was followed by the Student-T test, and a p-value less than 0.05 was considered statistically significant.
Results
Demographic data of the 3 groups are showed in Table 1 . There were no significant differences in age, sex, number of bypass grafts, CPB time, aortic cross clamp time (ACCT) and intra-aortic balloon pumping (IABP) support between the three groups. The doses of DOB and DOA of 
all groups Also did not have any significant differences. All the patients were weaned from CPB easily, and no critical arrhythmia occurred. They were discharged from hospital without any complications. There were no early or late death cases. In all cases, catecholamine, milrinone and olprinone were discontinued 72 h after the operation. In Group-M and Group-O, there were no cases where PDE inhibitors had to be discontinued because of low AoP. After surgery, no unusual bleeding was observed in any cases.
The changes of mean AoP and PAP are shown in Table 2 . Group-M demonstrated a significantly (p<0.01) lower mean AoP than Group-C only 3 h after the operation.
However, there were no significant differences from 6 to 72 h after the operation between the 2 groups. Group-O had a significantly lower Mean AoP than Group-C at 3-72 h after the operation, except at 24 h. Between Group-M and Group-O, there were no significant differences in mean AoP, except at 48 h after the operation (p<0.05). There were no significant differences in mean PAP between Group-M and Group-C except at 48 h after the operation. Group-O demonstrated a significantly lower mean PAP than Group-C from 3 to 72 h after the surgery. Group-O also showed a significantly lower mean PAP than Group-M except at 24 and 48 h after the operation.
The CI of Group-M was significantly higher than in Group-C until 2 days after the surgery. Similarly, the CI of Group-O was significantly higher than in Group-C from just after until 6 h after the surgery. However, there were no significant differences in CI between Group-M and Group-O (Fig 1) . The changes in PCWP and CVP of the 3 groups are shown in Table 3 . There were almost no significant differences in PCWP and CVP between Group-M and Group-C.
The PCWP value of Group-O was significantly (p<0.01) lower than that of Group-C, except at 48 h after the operation. At 12 and 48 h after CABG, the CVP of Group-O was significantly lower than that of Group-C. The PCWP of Group-O was significant (p<0.05) lower than that of Group-M from 3 to 12 h after the operation. The CVP of Group-O was also significant (p<0.05) lower than that of Group-M at 3 and 6 h after the surgery. Although there were almost no significant differences in PVRI between the 3 groups (Fig 2) , the SVRI values of Group-M and Group-O were significantly lower than that of Group-C. The SVRI of Group-M was significantly (p<0.01) lower than that of Group-C at 3, 6 and 12 h after the operation. Until 24 h after the CABG, the SVRI value of Group-O was significantly lower than that of Group-C. However, there were no significant differences in SVRI between Group-M and Group-O (Fig 3) .
There were almost no significant differences in DO2, VO2 and ER between the 3 groups (Table 4) .
Discussion
Several PDE inhibitors has been developed, tested experimentally and evaluated clinically. They are noncatecholamine, nonglycosidic inotropic agents that increase myocardial cyclic adenosine monophosphate (c-AMP) concentration by selective inhibition of cardiac PDE fraction III enzymes and increase intracellular calcium delivery, thereby increasing myocardial contractility. 9 It also increases c-AMP in vascular smooth muscle, showing direct vasodilator activity. 10 Its combination of positive inotropic and vasodilating effects is ideal in a drug for severe congestive heart failure. It is well tolerated with fewer adverse effects. 11 Despite these advantages, it is unknown whether this drug can be used for weaning from CPB, and few data are available concerning its effects on post-cardiotomy cardiogenic shock. In addition, the standard dose and appropriate infusion method of PDE inhibitors after cardiac surgery have not been established.
The clinical reports of amlinone, which is the more popular PDE inhibitor and has been widely used, demonstrated that AoP dropped significantly after intravenous bolus infusion. 12, 13 Milrinone, which is a more powerful PDE inhibitor, and olprinone, which has been shown to have a positive inotropic effect with a remarkable vasodilating effect, 6, 7, 14 may also decrease AoP because of their direct vasodilating activity. In the present study, in order to avoid any hypotension caused by milrinone and olprinone, we chose continuous intravenous low-dose administration of these drugs (milrinone: 0.25 g kg -1 min -1 ; olprinone: 0.1 g kg -1 min -1 ) as a safer and more appropriate infusion method during the unstable hemodynamics in the early postoperative period. These are the lowest dose rates that can be effected for these PDE inhibitors, according to the clinical investigations. 4, 6 In addition, to prevent a significant decrease in AoP, continuous intravenous low-dose catecholamines (3 g kg -1 min -1 of DOA and DOB) were used concomitantly. This study demonstrated a significant decrease in mean AoP in both Group-M and Group-O as compared with Group-C. In particular, the mean AoP of Group-O showed a significantly lower level than that of Group-C from 3 to 72 h after the surgery except at 24 h (Table 2 ). This was caused by the strong direct vasodilating effect of the PDE inhibitors. When the mean AoP drops below 50 mmHg, autoregulation of the kidney ceases and blood flow in cortex and medulla decreases as renal arterial pressure declines. 15 However, both groups were maintained in the range of 75-85 mmHg with no significant differences, indicating enough perfusion pressure for microcirculation of major organs, especially in the kidney. So in fact there were no cases of renal failure or other major organ failures.
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Pre Thus the decreased AoP due to milrinone and olprinone was not regarded as a problem after CABG. The CI of both Group-M and Group-O was significantly higher than in Group-C from the early postoperative period (Fig 1) , which means the PDE inhibitors improved myocardial contractility and stabilized its function in this period that sometimes demonstrates unstable hemodynamics. Both milrinone and olprinone increased the CI to almost the same level because there were no significant differences between Group-M and Group-O. The SVRI of Group-M and Group-O showed a significantly lower level than that of Group-C, indicating a decreasing left ventricle afterload due to the direct vasodilating activity of the PDE inhibitors, which played a significant role in increasing the CI (Fig 3) .
Although there have been some reports that milrinone decreased PAP and PVRI, 16,17 they did not change in the present study and there were no significant differences between Group-M and Group-C ( Table 2, Fig 2) . In these elective CABG cases, pre-operative PAP and PVRI were generally low enough, indicating a normal range, and they did not change significantly in the postoperative period. The changes in both PAP and PVRI in the 3 groups were also in the normal ranges before and after the operation. In addition, the dose of milrinone in Group-M was low. These factors may be the cause in that there were no changes and no significant differences. On the other hand, the mean PAP of Group-O was significantly lower than that of Group-C (Table 2) . However, as for PVRI, there were almost no significant differences between Group-O and Group-C (Fig 2) . In the present study, olprinone significantly reduced the PCWP, which means the preload of the left ventricle ( Table 3 ), and that may have caused a significant decrease in the right ventricle afterload in terms of mean PAP. Therefore, from this study we are not able to be conclusive in regard to PAP and PVRI. Additional trials, using higher doses and/or a single infusion of these PDE inhibitors, are necessary.
In the present study, although there were almost no significant differences in PCWP between Group-M and Group-C, olprinone significantly reduced left ventricular preload in terms of PCWP, as compared with milrinone and the control group (Table 3) . Despite the reduction of left heart preload, the increased CI with olprinone may be mainly related to the improvement of left ventricle contractility. Olprinone also reduced right heart preload in terms of CVP, indicating significant differences as compared with Group-M and Group-C (Table 3) , which means olprinone may improve right ventricle function. However, due to its remarkable vasodilating effect, it will easily cause hypovolemia and may lead to hypotension. Therefore, when this PDE inhibitor is used, especially in the early postoperative period after cardiac surgery, volume loading and/or concomitant usage of some inotropic agents may have to be used as well.
A continuous cardiac output/oxymetry system was introduced in this study. Using this system, DO2 and VO2 were measured as the parameters of oxygen supply and demand in peripheral tissue. Data from both Group-M and Group-O indicated normal values, and 3 were no significant differences between the 3 groups. The ER also showed no significant differences between the 3 groups, indicating reasonable values (Table 4) . Those results mean that oxygen supply and demand in peripheral tissue was in good balance in all groups. 18 
Conclusion
Both milrinone and olprinone increased the CI and decreased the SVRI to almost the same degree. Olprinone decreased mean AoP and PAP more than milrinone, but hypotension was not a problem. Olprinone also significantly reduced both PCWP and CVP more than milrinone. The concomitant usage of PDE inhibitors and low dose catecholamines successfully prevented significant hypotension. It allowed easy weaning from CPB, demonstrating excellent hemodynamics after CABG. Good oxygen demand and supply balance were revealed in peripheral tissues. These results suggest that the new PDE inhibitors may be effective not only for weaning from CPB but also for post-cardiotomy cardiogenic shock.
